The latest report by IMARC Group, titled “Ophthalmic Lasers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global ophthalmic lasers market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.91% during 2023-2028.
Ophthalmic lasers refer to the medical equipment that is utilized to treat numerous eye problems with minimum risk of infection. It is currently available as carbon dioxide (CO2), neodymium-doped yttrium aluminum garnet (Nd:YAG), excimer, argon, tunable dye, and diode lasers. It is utilized for the treatment of glaucoma, diabetic retinopathy, refractive eye and cataract surgery, retinal holes and retinal detachments, vein occlusions, wild hair on the eyelid, and macular degeneration. It offers pain-free treatment, reduces eye pressure, and can be performed on an outpatient basis. It assists in providing safety, efficacy, accuracy, and cost-efficiency to individuals suffering from various eye disorders as compared to traditional techniques.
For an in-depth analysis, you can refer sample copy of the report:https://www.imarcgroup.com/acne-drugs-market/requestsample
Ophthalmic Lasers Market Trends and Drivers:
Presently, the increasing prevalence of eye-related disorders among individuals due to an improper diet represents one of the primary factors contributing to the market growth. Besides this, the growing awareness among individuals about several ophthalmic diseases, along with the increasing spending on maintaining proper eye health, is offering a positive market outlook. Apart from this, the rising adoption of laser-assisted in situ keratomileusis (LASIK) surgery for refractive error correction is propelling the growth of the market. Moreover, technological advancements in ophthalmic lasers, such as selective laser trabeculoplasty (SLT), are offering lucrative growth opportunities to industry investors. Furthermore, the rising demand for safe and effective procedures, such as laser vision correction (LVC) for removing the requirement for glasses or contact lenses, is strengthening the market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Diode Lasers
- Femtosecond Lasers
- Excimer Lasers
- Nd: YAG Lasers
- SLT Lasers
- Others
Breakup by Indication:
- Glaucoma
- Cataract Removal
- Refractive Error Corrections
- Diabetic Retinopathy
- Others
Breakup by End-User:
- Hospitals
- Eye Clinics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Alcon Laboratories Inc. (Novartis AG)
- Johnson & Johnson Surgical Vision Inc.
- Bausch + Lomb
- Ellex Medical Lasers Limited
- IRIDEX Corporation
- Lumenis
- Topcon
- A.R.C. Laser
- Abbott Medical Optics
- Calmar Laser
- Carl Zeiss Meditec
- Meridian
- Nidek
- Optos
- Quantel
- Ziemer
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
